AL
MRSH

Aspiriant LLC’s Marsh MRSH Stock Holding History

Aspiriant LLC’s Portfolio MRSH Stock Details MRSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
+1,731
New +$289K 0.01% 326

Other funds holding MRSH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Aspiriant LLC's MRSH Position: Q2 2026 in Review

Aspiriant LLC opened a new position in Marsh (MRSH) in Q2 2026: 1,731 shares worth $289K. The stake represents 0.01% of the portfolio and ranks #326 among its holdings.

1,498 funds tracked by Wall St. Rank hold MRSH as of Q2 2026.

  • Aspiriant LLC held 1,731 shares of Marsh worth $289K as of Q2 2026.
  • Marsh was a new Aspiriant LLC position in Q2 2026.
  • Marsh made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #326 holding.
  • 1,498 funds tracked by Wall St. Rank held Marsh as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.